Aachen, Germany – Global pharmaceutical company Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will be taking on the role of Chief Commercial Officer (CCO) effective October 1st, 2024. Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since joining Grünenthal in 2017…
No responses yet